Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics, Boehringer Affiliate Enter AIDS Drug Research Pact

NEW YORK, Dec. 17 — Structural Bioinformatics said on Monday it has formed a research partnership with a Boehringer Ingelheim affiliate in Canada to discover new drug targets against HIV.

 

According to San Diego-based SBI, the collaboration will allow researchers at Boehringer Ingelheim in Canada to use its database of 3-D protein structures as part of in silico drug-discovery efforts.

 

SBI's database, called Variome, is a structural pharmacogenomic database with more than 100,000 variant 3-D protein structures for HIV protease and reverse transcriptase. It links nucleotide sequences and structural data with demographic and clinical annotations.

 

The partnership will allow Boehringer Ingelheim scientists to predict drug activity and prioritize potential compounds, SBI chairman and CEO Edward T. Maggio said in a statement. Researchers will use the database to incorporate information about viral mutations into drug design.

 

Financial terms of the deal were not disclosed.

 

Boehringer Ingelheim (Canada) is based in Burlington, Ontario. Its Laval, Quebec pharmaceutical research center, where researchers will use the SBI database, has a focus in virology.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.